Guardant Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on December 5, 2019, covering the event date of December 2, 2019. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Redwood City, California. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "GH".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
The primary material change reported is the departure of a senior executive:
- Departure: Richard Lanman, M.D., Chief Medical Officer, notified the Company of his decision to retire effective December 31, 2019.
- Service History: Dr. Lanman served as Chief Medical Officer since 2014 and was instrumental in establishing clinical development and physician education programs.
- Transition Plan: The Company is initiating a search for a new Chief Medical Officer. Dr. Lanman will remain with the Company as an advisor to facilitate the transition.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks, contingencies, or unusual items were disclosed in this report other than the standard operational risk associated with executive turnover.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new Chief Medical Officer.
- Review subsequent filings for details on the transition plan and Dr. Lanman's advisory role.
- Assess the potential impact of this leadership change on ongoing clinical development programs.